EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CXCR3-Expressing T Cells in Infections and Autoimmunity

Artem Rubinstein, Igor Kudryavtsev, Natalia Arsentieva, Zoia R Korobova, Dmitry Isakov, Areg A Totolian

Frontiers in Bioscience-Landmark · 22.08.2024 · 29 (8)

DOI: 10.31083/j.fbl2908301 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 22.08.2024. Verfasst von Artem Rubinstein und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Medical Faculty, First Saint Petersburg State I. Pavlov Medical University, 197022 Saint Petersburg, Russia. Hauptthemen laut MEDLINE: Receptors, CXCR3, Autoimmunity. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 473 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saint Petersburg Pasteur Institute via the State Task, Institute of Experimental Medicine via the State Task.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3+ Treg cells, and Tc1 CD8+ T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4+ and CD8+ T cells that upregulate inflammation, and also for recruitment of CXCR3+ T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CXCR3AutoimmunityHumansAnimalsInfectionsT-LymphocytesInflammationAutoimmune Diseases

Stichwörter der Autor:innen

COVID-19CXCR3 chemokinesCXCR3 receptorCXCR3+ TregTc1Th1 cellsTh17.1 cellsautoimmunityfollicular Th cell subsetsinfection

Substanzen

Receptors, CXCR3CXCR3 protein, human

Autor:innen und Institutionen

  • Department of Immunology, Medical Faculty, First Saint Petersburg State I. Pavlov Medical University, 197022 Saint Petersburg, Russia.
  • Department of Immunology, Institute of Experimental Medicine, 197376 Saint Petersburg, Russia.
  • Laboratory of Immunology, Saint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia.

Förderung

  • Saint Petersburg Pasteur Institute via the State Task
  • Institute of Experimental Medicine via the State Task

Zitieren

APA

Rubinstein, A., Kudryavtsev, I., Arsentieva, N., Korobova, Z. R., Isakov, D., & Totolian, A. A. (2024). CXCR3-Expressing T Cells in Infections and Autoimmunity. Frontiers in Bioscience-Landmark, 29(8). https://doi.org/10.31083/j.fbl2908301

Vancouver

Rubinstein A, Kudryavtsev I, Arsentieva N, Korobova ZR, Isakov D, Totolian AA. CXCR3-Expressing T Cells in Infections and Autoimmunity. Frontiers in Bioscience-Landmark. 2024;29(8). doi:10.31083/j.fbl2908301

BibTeX
@article{Rubinstein2024,
  author = {Rubinstein, Artem and Kudryavtsev, Igor and Arsentieva, Natalia and Korobova, Zoia R and Isakov, Dmitry and Totolian, Areg A},
  title = {CXCR3-Expressing T Cells in Infections and Autoimmunity},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  volume = {29},
  number = {8},
  doi = {10.31083/j.fbl2908301}
}
Kostenlos starten →